Aridis Pharmaceuticals, Inc. Gains 21.25%
Mon, Jan 24, 2022 at 05:30 PM
Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) soared at $1.94, a gain of 21.3%. On Fri, Jan 21, 2022, ARDS:NASDAQ touched a New 2-Week Intraday High of $1.69. The stock got featured on our News Catalysts scanner on Wed, Dec 29, 2021 at 02:05 PM in the 'MISCELLANEOUS' category. From Mon, Jan 10, 2022, the stock recorded 25.00% Up Days and 33.33% Green Days
The stock spiked on Tue, Dec 21, 2021 at $4.34 with a volume of 43M+.
About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Top 10 Gainers:
- Exterran Corporation (EXTN:NYSE), 59.67%
- ShiftPixy, Inc. (PIXY:NASDAQ), 38.71%
- Kohl's Corporation (KSS:NYSE), 36.02%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 26.99%
- Sweetgreen Inc. Class A (SG:NYSE), 23.34%
- Gelesis Holdings Inc. (GLS:NYSE), 22.37%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 21.25%
- Atlas Technical Consultants, Inc. (ATCX:NASDAQ), 20.13%
- Immunome Inc. (IMNM:NASDAQ), 19.46%
- Akouos Inc. (AKUS:NASDAQ), 19.14%